These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39578847)
1. The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better. Loria F; Mone P; Rispoli A; Di Fonzo R; Masarone D; Mancusi C; Correale M; Vitullo A; Granatiero M; Mazzeo P; Mercurio V; Fiore F; Di Sarro E; Falco L; Izzo C; Campanile A; Virtuoso N; Stabile E; Bonanno S; Dattilo G; Tocchetti CG; Santulli G; Vecchione C; Ciccarelli M; Visco V Cardiovasc Diabetol; 2024 Nov; 23(1):423. PubMed ID: 39578847 [TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome. Pastore MC; Stefanini A; Mandoli GE; Piu P; Diviggiano EE; Iuliano MA; Carli L; Marchese A; Martini L; Pecere A; Cavigli L; Giacomin E; Pagliaro A; Righini FM; Sorini Dini C; Soliman Aboumarie H; Focardi M; D'Ascenzi F; Valente S; Cameli M JACC Cardiovasc Imaging; 2024 Dec; 17(12):1399-1408. PubMed ID: 39023499 [TBL] [Abstract][Full Text] [Related]
3. Effect of optimisation to contemporary HFrEF medical therapy with sacubitril/valsartan (Entresto) and dapaglifloziN on left Ventricular reverse remodelling as demonstrated by cardiac magnetic resonance (CMR) Imaging: the ENVI study. Zheng A; Adam R; Peebles C; Harden S; Shambrook J; Abbas A; Vedwan K; Adam G; Haydock P; Cowburn P; Young C; Long J; Walkden M; Smith S; Greenwood E; Olden P; Flett A Open Heart; 2024 Dec; 11(2):. PubMed ID: 39622578 [TBL] [Abstract][Full Text] [Related]
4. Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis. Yan Q; Chen X; Yu C; Yin Y BMC Cardiovasc Disord; 2024 Nov; 24(1):663. PubMed ID: 39578752 [TBL] [Abstract][Full Text] [Related]
5. Effects of sacubitril/valsartan on renal function and outcome in patients with heart failure and reduced ejection fraction: an Italian cohort study. Palazzuoli A; Pirrotta F; Cartocci A; Delcuratolo E; Dini FL; Correale M; Dattilo G; Masarone D; Scelsi L; Ghio S; Tocchetti CG; Mercurio V; Brunetti ND; Nodari S; Barillà F; Ambrosio G; Carluccio E Ther Adv Cardiovasc Dis; 2024; 18():17539447241285136. PubMed ID: 39611607 [TBL] [Abstract][Full Text] [Related]
6. CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICLE EJECTION FRACTION (HFPEF) AND RIGHT VENTRICLE INVOLVEMENT IN PATIENTS WITH NORMAL SINUS RHYTHM AND ATRIAL FIBRILLATION; A SMALL OBSERVATIONAL STUDY: RELEVANCE OF THE PROBLEM, DIAGNOSTIC APPROACH, ECHOCARDIOGRAPHIC EVALUATION OF RIGHT VENTRICLE. Kobalava S; Tsverava M; Tsetskhladze E Georgian Med News; 2024 Sep; (354):66-74. PubMed ID: 39580830 [TBL] [Abstract][Full Text] [Related]
7. Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis. Savage P; Watson C; Coburn J; Cox B; Shahmohammadi M; Grieve D; Dixon L ESC Heart Fail; 2024 Dec; 11(6):3636-3648. PubMed ID: 39056515 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
9. Echocardiographic Evaluation in Cardiac Resynchronization Therapy: A Single Center Experience. AlRahimi JS; SaemAldahar AA; Bahshwan AH; Alsulaimani JG; Ismail YM; Jelaidan I Cureus; 2024 Nov; 16(11):e74344. PubMed ID: 39583605 [TBL] [Abstract][Full Text] [Related]
10. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
11. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
12. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
13. Budget Impact Analysis of Dapagliflozin in Treating Patients With Heart Failure With Reduced Ejection Fraction From the Perspective of Malaysian Public Healthcare System. Tan YJ; Low JZ; Ong SC Clin Ther; 2024 Nov; 46(11):e1-e9. PubMed ID: 39261261 [TBL] [Abstract][Full Text] [Related]
14. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults. Huang Y; Trollor JN; Foley KR; Arnold SRC Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050 [TBL] [Abstract][Full Text] [Related]
15. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]
16. Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection? Castillo RL; Farías J; Sandoval C; González-Candia A; Figueroa E; Quezada M; Cruz G; Llanos P; Jorquera G; Kostin S; Carrasco R Antioxidants (Basel); 2024 Nov; 13(11):. PubMed ID: 39594530 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related]